Latest Talk
[DIA Europe 2024] Drug Repurposing: Opportunities & Challenges
Drug repurposing is regarded as a potential solution to treatment gaps and increasing healthcare costs, especially after COVID. However, this complex topic grants deeper discussion and a collaborative, multi-stakeholder approach.
On-demand Talks
![[DIA Europe 2024] How to Build a Sustainable Pharmacovigilance Ecosystem?](https://cdn.brighttalk.com/ams/california/images/communication/620595/image_992991.png?width=640&height=360)
![[DIA Europe 2024] HTA Townhall – Ready for 2025 EU Joint Clinical Assessment](https://cdn.brighttalk.com/ams/california/images/communication/620168/image_992140.png?width=640&height=360)
![[DIA Europe 2024] Environment, Equity and Future-Proofing in Healthcare Systems](https://cdn.brighttalk.com/ams/california/images/communication/620167/image_992134.png?width=640&height=360)
![[DIA Europe 2024] Preference Studies in Regulatory and Payers' Decisions](https://cdn.brighttalk.com/ams/california/images/communication/619777/image_992126.png?width=640&height=360)
![[DIA Europe 2024] Impact of the New Pharma Legislation on Regulatory Operations](https://cdn.brighttalk.com/ams/california/images/communication/619771/image_991142.png?width=640&height=360)
![[DIA Europe 2024] Reimagining Labelling E2E Process: EU Centralised Procedure](https://cdn.brighttalk.com/ams/california/images/communication/619722/image_991060.png?width=640&height=360)
![[DIA Europe 2024] Medical Devices in Clinical Trials](https://cdn.brighttalk.com/ams/california/images/communication/619470/image_990619.png?width=640&height=360)
Related topics: